Alexander S. Clanachan

5.1k total citations
131 papers, 4.1k citations indexed

About

Alexander S. Clanachan is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Alexander S. Clanachan has authored 131 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pathology and Forensic Medicine, 52 papers in Cardiology and Cardiovascular Medicine and 38 papers in Molecular Biology. Recurrent topics in Alexander S. Clanachan's work include Cardiac Ischemia and Reperfusion (60 papers), Cardiac Arrest and Resuscitation (28 papers) and Adenosine and Purinergic Signaling (26 papers). Alexander S. Clanachan is often cited by papers focused on Cardiac Ischemia and Reperfusion (60 papers), Cardiac Arrest and Resuscitation (28 papers) and Adenosine and Purinergic Signaling (26 papers). Alexander S. Clanachan collaborates with scholars based in Canada, United States and Switzerland. Alexander S. Clanachan's co-authors include Gary D. Lopaschuk, Manoj Gandhi, Barry A. Finegan, Richard Schulz, James R. Hammond, Gary D. Lopaschuk, Michael Zaugg, Eliana Lucchinetti, Bodh I. Jugdutt and Jason R.B. Dyck and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Gastroenterology.

In The Last Decade

Alexander S. Clanachan

131 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander S. Clanachan Canada 36 1.7k 1.5k 1.1k 720 649 131 4.1k
Kazuo Komamura Japan 42 1.6k 1.0× 2.7k 1.8× 856 0.7× 706 1.0× 1.0k 1.6× 182 5.8k
M Hori Japan 35 1.0k 0.6× 1.3k 0.8× 1.6k 1.4× 399 0.6× 826 1.3× 89 4.2k
Masaya Tanno Japan 36 2.2k 1.3× 949 0.6× 1.2k 1.0× 875 1.2× 465 0.7× 122 4.6k
Tsunehiko Kuzuya Japan 37 1.7k 1.0× 1.9k 1.3× 1.2k 1.0× 805 1.1× 439 0.7× 101 4.5k
Lei Xi United States 37 1.6k 1.0× 1.2k 0.8× 1.2k 1.0× 1.0k 1.4× 336 0.5× 97 4.3k
Anindita Das United States 44 2.6k 1.6× 1.7k 1.1× 896 0.8× 795 1.1× 550 0.8× 103 5.2k
Atsushi Kuno Japan 37 1.8k 1.1× 626 0.4× 772 0.7× 747 1.0× 492 0.8× 126 4.1k
Bernward A. Schölkens Germany 45 2.3k 1.4× 4.1k 2.7× 1.2k 1.0× 1.3k 1.9× 510 0.8× 125 7.8k
Guro Valen Sweden 35 1.7k 1.0× 1.0k 0.7× 1.2k 1.1× 414 0.6× 672 1.0× 133 4.0k
Tiziano M. Scarabelli United States 35 1.3k 0.8× 1.2k 0.8× 729 0.6× 411 0.6× 502 0.8× 100 4.1k

Countries citing papers authored by Alexander S. Clanachan

Since Specialization
Citations

This map shows the geographic impact of Alexander S. Clanachan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander S. Clanachan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander S. Clanachan more than expected).

Fields of papers citing papers by Alexander S. Clanachan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander S. Clanachan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander S. Clanachan. The network helps show where Alexander S. Clanachan may publish in the future.

Co-authorship network of co-authors of Alexander S. Clanachan

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander S. Clanachan. A scholar is included among the top collaborators of Alexander S. Clanachan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander S. Clanachan. Alexander S. Clanachan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lou, Phing‐How, Eliana Lucchinetti, Martin Hersberger, Alexander S. Clanachan, & Michael Zaugg. (2019). Lipid Emulsion Containing High Amounts of n3 Fatty Acids (Omegaven) as Opposed to n6 Fatty Acids (Intralipid) Preserves Insulin Signaling and Glucose Uptake in Perfused Rat Hearts. Anesthesia & Analgesia. 130(1). 37–48. 4 indexed citations
2.
Alrob, Osama Abo, et al.. (2015). Tolerance to ischaemic injury in remodelled mouse hearts: less ischaemic glycogenolysis and preserved metabolic efficiency. Cardiovascular Research. 107(4). 499–508. 6 indexed citations
3.
Xu, Jinjin, Haobo Li, Michael G. Irwin, et al.. (2014). Propofol Ameliorates Hyperglycemia-Induced Cardiac Hypertrophy and Dysfunction via Heme Oxygenase-1/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Rats*. Critical Care Medicine. 42(8). e583–e594. 31 indexed citations
4.
Soraya, Hamid, Alexander S. Clanachan, Maryam Rameshrad, et al.. (2014). Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction. European Journal of Pharmacology. 737. 77–84. 53 indexed citations
5.
Lou, Phing‐How, Eliana Lucchinetti, Liyan Zhang, et al.. (2014). Loss of Intralipid®- but Not Sevoflurane-Mediated Cardioprotection in Early Type-2 Diabetic Hearts of Fructose-Fed Rats: Importance of ROS Signaling. PLoS ONE. 9(8). e104971–e104971. 10 indexed citations
6.
Zaugg, Michael, et al.. (2014). Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications. Current Pharmaceutical Design. 20(36). 5706–5726. 31 indexed citations
7.
Zaugg, Michael, Lianguo Wang, Liyan Zhang, et al.. (2012). Choice of Anesthetic Combination Determines Ca2+Leak after Ischemia-Reperfusion Injury in the Working Rat Heart. Anesthesiology. 116(3). 648–657. 16 indexed citations
8.
Lucchinetti, Eliana, Lukas Bestmann, Jianhua Feng, et al.. (2012). Remote Ischemic Preconditioning Applied during Isoflurane Inhalation Provides No Benefit to the Myocardium of Patients Undergoing On-pump Coronary Artery Bypass Graft Surgery. Anesthesiology. 116(2). 296–310. 106 indexed citations
9.
Lucchinetti, Eliana, Lianguo Wang, Kerry W.S. Ko, et al.. (2011). Enhanced glucose uptake via GLUT4 fuels recovery from calcium overload after ischaemia–reperfusion injury in sevoflurane- but not propofol-treated hearts. British Journal of Anaesthesia. 106(6). 792–800. 16 indexed citations
10.
Wang, Lianguo, Kerry W.S. Ko, Eliana Lucchinetti, et al.. (2010). Metabolic Profiling of Hearts Exposed to Sevoflurane and Propofol Reveals Distinct Regulation of Fatty Acid and Glucose Oxidation. Anesthesiology. 113(3). 541–551. 25 indexed citations
11.
Omar, Mohamed A., Heather Fraser, & Alexander S. Clanachan. (2008). Ischemia-induced activation of AMPK does not increase glucose uptake in glycogen-replete isolated working rat hearts. American Journal of Physiology-Heart and Circulatory Physiology. 294(3). H1266–H1273. 15 indexed citations
12.
Belardinelli, Luiz, et al.. (2006). Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts. Journal of Molecular and Cellular Cardiology. 41(6). 1031–1038. 107 indexed citations
13.
Folmes, Clifford D.L., Alexander S. Clanachan, & Gary D. Lopaschuk. (2005). Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis. Current Atherosclerosis Reports. 7(1). 63–70. 29 indexed citations
14.
Kumar, Dinender, et al.. (2004). Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinases during myocardial ischemia-reperfusion. Molecular and Cellular Biochemistry. 258(1-2). 211–218. 9 indexed citations
15.
Clanachan, Alexander S., Jagdip S. Jaswal, Manoj Gandhi, et al.. (2003). Effects of inhibition of myocardial extracellular-responsive kinase and P38 mitogen-activated protein kinase on mechanical function of rat hearts after prolonged hypothermic ischemia. Transplantation. 75(2). 173–180. 31 indexed citations
16.
Liu, Que, et al.. (2002). High levels of fatty acids delay the recoveryof intracellular pH and cardiac efficiency inpost-ischemic hearts by inhibiting glucose oxidation. Journal of the American College of Cardiology. 39(4). 718–725. 205 indexed citations
17.
Fraser, Heather, Gary D. Lopaschuk, & Alexander S. Clanachan. (1999). Alteration of glycogen and glucose metabolism in ischaemic and post‐ischaemic working rat hearts by adenosine A1 receptor stimulation. British Journal of Pharmacology. 128(1). 197–205. 46 indexed citations
18.
Fraser, Heather, Sandra T. Davidge, & Alexander S. Clanachan. (1999). Enhancement of Post-ischemic Myocardial Function by Chronic 17β-Estradiol Treatment: Role of Alterations in Glucose Metabolism. Journal of Molecular and Cellular Cardiology. 31(8). 1539–1549. 24 indexed citations
19.
Finegan, Barry A., Gary D. Lopaschuk, Manoj Gandhi, & Alexander S. Clanachan. (1996). Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischaemia. British Journal of Pharmacology. 118(2). 355–363. 61 indexed citations
20.
Finegan, Barry A. & Alexander S. Clanachan. (1991). Comparison of the haemodynamic effects of adenosine monophosphate with sodium nitroprusside in a canine model of acute global left ventricular dysfunction. British Journal of Pharmacology. 103(3). 1691–1696. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026